Major depressive disorder and accelerated cellular aging: Results from a large psychiatric cohort study

Molecular Psychiatry

Volumn 19, Issue 8, 2014, Pages 895-901

  Verhoeven, J E ^a   Revesz D ^a   Epel, E S ^b   Lin, J ^b   Wolkowitz, O M ^b   Penninx, B W J H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cell aging; depression; mood disorders; telomere shortening

Indexed keywords

BENZODIAZEPINE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CELL AGING; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENE DOSAGE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NETHERLANDS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; REMISSION; SELF REPORT; STRUCTURED INTERVIEW; TELOMERE; ADOLESCENT; CASE CONTROL STUDY; GENETICS; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX; TELOMERE SHORTENING; YOUNG ADULT; ALCOHOLISM; ANXIETY DISORDER; COMORBIDITY; COPY NUMBER VARIATION; DEMOGRAPHY; DRUG USE; ONSET AGE; SOCIAL STATUS; TELOMERE HOMEOSTASIS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CELL AGING; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TELOMERE SHORTENING; YOUNG ADULT;

EID: 84905047389     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2013.151     Document Type: Article

References (65)

1. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: A meta-Analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763-2774. (Pubitemid 44871461)
2. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: A meta-Analysis. Diabetes Care 2008; 31: 2383-2390.
3. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW et al. Overweight, obesity, and depression: A systematic review and meta-Analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67: 220-229.
4. Gao y, Huang C, Zhao K, Ma L, Qiu X, Zhang L et al. Depression as a risk factor for dementia and mild cognitive impairment: A meta-Analysis of longitudinal studies. Int J Geriatr Psychiatry 2012; 28: 441-449.
5. Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival?. Nat Clin Pract Oncol 2008; 5: 466-475.
6. Penninx BW, Guralnik JM, Ferrucci L, Simonsick EM, Deeg DJ, Wallace RB. Depressive symptoms and physical decline in community-dwelling older persons. JAMA 1998; 279: 1720-1726. (Pubitemid 28247303)
7. Schulz R, Beach SR, Ives DG, Martire LM, Ariyo AA, Kop WJ. Association between depression and mortality in older adults: The Cardiovascular Health Study. Arch Intern Med 2000; 160: 1761-1768. (Pubitemid 30418812)
8. Cuijpers P, Smit F. Excess mortality in depression: A meta-Analysis of community studies. J Affect Disord 2002; 72: 227-236. (Pubitemid 35351282)
9. Wolkowitz OM, Epel ES, Reus VI, Mellon SH. Depression gets old fast: Do stress and depression accelerate cell aging?. Depress Anxiety 2010; 27: 327-338.
10. Wolkowitz OM, Reus VI, Mellon SH. Of sound mind and body: Depression, disease, and accelerated aging. Dialogues Clin Neurosci 2011; 13: 25-39.
11. Blackburn EH. Switching and signaling at the telomere. Cell 2001; 106: 661-673. (Pubitemid 32900658)
12. Epel ES. Psychological and metabolic stress: A recipe for accelerated cellular aging?. Hormones (Athens) 2009; 8: 7-22.
13. Olovnikov AM. Telomeres, telomerase, and aging: Origin of the theory. Exp Gerontol 1996; 31: 443-448. (Pubitemid 126745166)
14. Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: The path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 2006; 12: 1133-1138. (Pubitemid 44527346)
15. Fitzpatrick AL, Kronmal RA, Gardner JP, Psaty BM, Jenny NS, Tracy RP et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol 2007; 165: 14-21. (Pubitemid 46026204)
16. Valdes AM, Andrew T, Gardner JP, Kimura M, Oelsner E, Cherkas LF et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005; 366: 662-664. (Pubitemid 41176019)
17. Sampson MJ, Winterbone MS, Hughes JC, Dozio N, Hughes DA. Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care 2006; 29: 283-289. (Pubitemid 44106505)
18. Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, Brandstatter A et al. Telomere length and risk of incident cancer and cancer mortality. JAMA 2010; 304: 69-75.
19. Martin-Ruiz C, Dickinson HO, Keys B, Rowan E, Kenny RA, von Zglinicki T. Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann Neurol 2006; 60: 174-180. (Pubitemid 44182392)
20. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003; 361: 393-395. (Pubitemid 36164975)
21. Simon NM, Smoller JW, McNamara KL, Maser RS, Zalta AK, Pollack MH et al. Telomere shortening and mood disorders: Preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry 2006; 60: 432-435. (Pubitemid 44292160)
22. Lung FW, Chen NC, Shu BC. Genetic pathway of major depressive disorder in shortening telomeric length. Psychiatr Genet 2007; 17: 195-199. (Pubitemid 46716213)
23. Hartmann N, Boehner M, Groenen F, Kalb R. Telomere length of patients with major depression is shortened but independent from therapy and severity of the disease. Depress Anxiety 2010; 27: 1111-1116.
24. Hoen PW, de Jonge P, Na BY, Farzaneh-Far R, Epel E, Lin J et al. Depression and leukocyte telomere length in patients with coronary heart disease: Data from the Heart and Soul Study. Psychosom Med 2011; 73: 541-547.
25. Wolkowitz OM, Mellon SH, Epel ES, Lin J, Dhabhar FS, Su Y et al. Leukocyte telomere length in major depression: Correlations with chronicity, inflammation and oxidative stress-preliminary findings. PLoS One 2011; 6: E17837.
26. Wikgren M, Maripuu M, Karlsson T, Nordfjall K, Bergdahl J, Hultdin J et al. Short telomeres in depression and the general population are associated with a hypocortisolemic state. Biol Psychiatry 2012; 71: 294-300.
27. Penninx BWJH, Beekman ATF, Smit JH, Zitman FG, Nolen WA, Spinhoven P et al. The Netherlands Study of Depression and Anxiety (NESDA): Rationale, objectives and methods. Int J Methods Psychiatr Res 2008; 17: 121-140.
28. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS): Psychometric properties. Psychol Med 1996; 26: 477-486. (Pubitemid 26142491)
29. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30: E47.
30. Aviv A, Hunt SC, Lin J, Cao X, Kimura M, Blackburn E. Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots and qPCR. Nucleic Acids Res 2011; 39: E134.
31. Lin J, Epel E, Cheon J, Kroenke C, Sinclair E, Bigos M et al. Analyses and comparisons of telomerase activity and telomere length in human T and B cells: Insights for epidemiology of telomere maintenance. J Immunol Methods 2010; 352: 71-80.
32. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54: 573-583. (Pubitemid 37289444)
33. Lyketsos CG, Nestadt G, Cwi J, Heithoff K. The life-chart interview: A standardized method to describe the course of psychopathology. Int J Meth Psychiatr Res 1994; 4: 143-155.
34. de Graaf R, Bijl RV, Smit F, Vollebergh WAM, Spijker J. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: Findings from the Netherlands Mental Health Survey and Incidence Study. Am J Psychiatry 2002; 159: 620-629. (Pubitemid 34274945)
35. Hovens JG, Wiersma JE, Giltay EJ, van Oppen P, Spinhoven P, Penninx BW et al. Childhood life events and childhood trauma in adult patients with depressive, anxiety and comorbid disorders vs. controls. Acta Psychiatr Scand 2010; 122: 66-74.
36. Wiersma JE, Hovens JG, van OP, Giltay EJ, van Schaik DJ, Beekman AT et al. The importance of childhood trauma and childhood life events for chronicity of depression in adults. J Clin Psychiatry 2009; 70: 983-989.
37. Spinhoven P, Elzinga BM, Hovens JG, Roelofs K, Zitman FG, van Oppen P et al. The specificity of childhood adversities and negative life events across the life span to anxiety and depressive disorders. J Affect Disord 2010; 126: 103-112.
38. World Health Organization Collaboration Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification System. World Health Organization Collaboration Centre for Drug Statistics Methodology: Oslo, Norway, 2007.
39. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003; 35: 1381-1395. (Pubitemid 36936159)
40. Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR Jr, Tudor-Locke C et al. 2011 Compendium of physical activities: A second update of codes and MET values. Med Sci Sports Exerc 2011; 43: 1575-1581.
41. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-Analysis. Psychosom Med 2009; 71: 171-186.
42. Molendijk M, Bus B, Oude Voshaar R, Spinhoven P, Penninx BW, Elzinga B. Serum levels of brain-derived neurotrophic factor in major depressive disorder: State-Trait issues, clinical features, and pharmacological treatment. Mol Psychiatry 2010; 16: 1088-1095.
43. Vreeburg SA, Hoogendijk WJ, van PJ, Derijk RH, Verhagen JC, van Dyck R et al. Major depressive disorder and hypothalamic-pituitary-Adrenal axis activity: Results from a large cohort study. Arch Gen Psychiatry 2009; 66: 617-626.
44. Price LH, Kao HT, Burgers DE, Carpenter LL, Tyrka AR. Telomeres and early-life stress: An overview. Biol Psychiatry 2013; 73: 15-23.
45. Penninx BW, Beekman AT, Bandinelli S, Corsi AM, Bremmer M, Hoogendijk WJ et al. Late-life depressive symptoms are associated with both hyperactivity and hypoactivity of the hypothalamo-pituitary-Adrenal axis. Am J Geriatr Psychiatry 2007; 15: 522-529.
46. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK et al. A metaanalysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446-457.
47. Vogelzangs N, Duivis HE, Beekman ATF, Kluft C, Neuteboom J, Hoogendijk W et al. Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl Psychiatry 2012; 2: E79.
48. Rottenberg J. Cardiac vagal control in depression: A critical analysis. Biol Psychol 2007; 74: 200-211. (Pubitemid 44969448)
49. Licht CM, de Geus EJ, Zitman FG, Hoogendijk WJ, van DR, Penninx BW. Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Arch Gen Psychiatry 2008; 65: 1358-1367.
50. Michel TM, Pulschen D, Thome J. The role of oxidative stress in depressive disorders. Curr Pharm Des 2012; 18: 5890-5899.
51. Choi J, Fauce SR, Effros RB. Reduced telomerase activity in human T lymphocytes exposed to cortisol. Brain Behav Immun 2008; 22: 600-605.
52. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27: 339-344. (Pubitemid 34756516)
53. Damjanovic AK, Yang Y, Glaser R, Kiecolt-Glaser JK, Nguyen H, Laskowski B et al. Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients. J Immunol 2007; 179: 4249-4254.
54. Aviv A, Chen W, Gardner JP, Kimura M, Brimacombe M, Cao X et al. Leukocyte telomere dynamics: Longitudinal findings among young adults in the Bogalusa Heart Study. Am J Epidemiol 2009; 169: 323-329.
55. Nordfjall K, Svenson U, Norrback KF, Adolfsson R, Lenner P, Roos G. The individual blood cell telomere attrition rate is telomere length dependent. PLoS Genet 2009; 5: E1000375.
56. Shalev I, Moffitt T, Sugden K, Williams B, Houts RM, Danese A et al. Exposure to violence during childhood is associated with telomere erosion from 5 to 10 years of age: A longitudinal study. Mol Psychiatry 2012; 18: 576-581.
57. Teyssier JR, Ragot S, Donzel A, Chauvet-Gelinier JC. [Telomeres in the brain cortex of depressive patients]. Encephale 2010; 36: 491-494.
58. Zhang D, Cheng L, Craig DW, Redman M, Liu C. Cerebellar telomere length and psychiatric disorders. Behav Genet 2010; 40: 250-254.
59. Zhou QG, Hu Y, Wu DL, Zhu LJ, Chen C, Jin X et al. Hippocampal telomerase is involved in the modulation of depressive behaviors. J Neurosci 2011; 31: 12258-12269.
60. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 2004; 101: 17312-17315. (Pubitemid 39627816)
61. Wolkowitz OM, Mellon SH, Epel ES, Lin J, Reus VI, Rosser R et al. Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response. Mol Psychiatry 2012; 17: 164-172.
62. Puterman E, Lin J, Blackburn E, O'Donovan A, Adler N, Epel E. The power of exercise: Buffering the effect of chronic stress on telomere length. PLoS One 2010; 5: E10837.
63. Du M, Prescott J, Kraft P, Han J, Giovannucci E, Hankinson SE et al. Physical activity, sedentary behavior, and leukocyte telomere length in women. Am J Epidemiol 2012; 175: 414-422.
64. Lin J, Epel E, Blackburn E. Telomeres and lifestyle factors: Roles in cellular aging. Mutat Res 2012; 730: 85-89.
65. Osthus IB, Sgura A, Berardinelli F, Alsnes IV, Bronstad E, Rehn T et al. Telomere length and long-Term endurance exercise: Does exercise training affect biological age?. A pilot study. PLoS One 2012; 7: E52769.